Fruit :: Fruit and vegetables health
FAV Health 2007, an International Symposium on Human Health Effects of Fruit and Vegetables (FAV) is scheduled for the first time in the United States from October 9 till 13 in Houston, TX.
Genome :: Researchers expand efforts to explore functional landscape of the human genome
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced grants totaling more than $80 million over the next four years to expand the ENCyclopedia Of DNA Elements (ENCODE) project, which in its pilot phase yielded provocative new insights into the organization and function of the human genome.
Immunity :: Mathematicians help unlock secrets of the immune system
A group of scientists, led by mathematicians, has taken on the challenge of building a common model of immune responses. Their work will radically improve our understanding of the human immune system by allowing all the scientific disciplines working on it to have a common reference point and language.
Ultrasound :: Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry
Gastroesophageal reflux arises from increased exposure and/or sensitivity of the esophageal mucosa to gastric contents, and affects 5-40 percent of the population. Esophageal ultrasound studies in GER have mainly focused on the evaluation of the gastroesophageal junction and esophageal motility performed by transabdominal or endoluminal routes. Visualizing refluxate in transcutaneous cervical esophageal ultrasound was found to be useful as a pre-diagnostic tool for estimating GER and/or manometric pathology in 71.1 percent of adults.
Nobel Prize :: Professor Sir Martin Evans wins Nobel Prize for Medicine
Professor Sir Martin Evans, Professor of Mammalian Genetics at the School of Biosciences, Cardiff University, has won the 2007 Nobel Prize for Medicine. The Nobel Assembly at the Karolinska Institute, Sweden, announced this morning that Professor Sir Martin was one of three winners for “a series of ground-breaking discoveries concerning embryonic stem cells and DNA recombination in mammals.”
Colorectal Cancer :: Interleukin-8, key marker for colorectal cancer treatment
Colorectal cancer (CRC) is currently one of the three most frequent malignancies in Western industrial nations. Although the 5-year survival rate for patients with early stage and local CRC approaches nearly 90%, survival is dramatically decreased by local recurrence and the development of distant metastases that primarily affect the liver, which are the predominant cause of CRC-related mortality.
Clinical Trial :: Paving the way for future pan-European clinical trials
Pan-European collaboration is important for many clinical trials and essential for trials that are investigating treatments for rare diseases. That was the message delivered today by the European Medical Research Councils (EMRC), the membership organisation for medical research councils across Europe based at the European Science Foundation (ESF) in Strasbourg, which is coordinating two trials in rare diseases and about to launch a review of how best to implement clinical trials that are initiated by investigators.
Mosquito :: MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR
MIT Holding, Inc. (OTCBB: MITD), in collaboration with MEVLABS and Georgia Southern University, have successfully tested prototype designs of the patent pending PROVECTOR™. This small dispensable device is designed to stop the development of pathogens and parasites found in mosquitoes that carry deadly diseases such as malaria, dengue fever, and West Nile virus.
Influenza :: Influenza – Insights into cell specificity of human vs. avian viruses
Researchers have identified which sites and cell types within the respiratory tract are targeted by human versus avian influenza viruses, providing valuable insights into the pathogenesis of these divergent diseases.
Heart Disease :: A lifestyle intervention for preventing cardiovascular disease
A standardized intervention incorporating risk assessment and telephone counselling improved cardiovascular risk factors among those at risk for coronary disease.